A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
Public ClinicalTrials.gov record NCT03813238. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
Study identification
- NCT ID
- NCT03813238
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Industry
- Enrollment
- 63 participants
Conditions and interventions
Conditions
Interventions
- TEV-50717 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 6 Years to 18 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 5, 2019
- Primary completion
- Jul 4, 2022
- Completion
- Jul 20, 2022
- Last update posted
- Sep 7, 2023
2019 – 2022
United States locations
- U.S. sites
- 23
- U.S. states
- 17
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Teva Investigational Site 14137 | Birmingham | Alabama | 35233 | — |
| Teva Investigational Site 14224 | Phoenix | Arizona | 85016 | — |
| Teva Investigational Site 14227 | Loma Linda | California | 92354 | — |
| Teva Investigational Site 14295 | San Diego | California | 92123 | — |
| Teva Investigational Site 14293 | Washington D.C. | District of Columbia | 20010 | — |
| Teva Investigational Site 14127 | Miami | Florida | 33155 | — |
| Teva Investigational Site 14125 | Tampa | Florida | 33609 | — |
| Teva Investigational Site 14136 | Atlanta | Georgia | 30318 | — |
| Teva Investigational Site 14291 | Atlanta | Georgia | 30328 | — |
| Teva Investigational Site 14130 | Savannah | Georgia | 31406 | — |
| Teva Investigational Site 14290 | New Orleans | Louisiana | 70118-5720 | — |
| Teva Investigational Site 14226 | Saint Paul | Minnesota | 55101 | — |
| Teva Investigational Site 14134 | Lincoln | Nebraska | 68526 | — |
| Teva Investigational Site 14122 | Gibbsboro | New Jersey | 08026 | — |
| Teva Investigational Site 14297 | New Brunswick | New Jersey | 08901 | — |
| Teva Investigational Site 14225 | New York | New York | 10032 | — |
| Teva Investigational Site 14123 | Rochester | New York | 14642 | — |
| Teva Investigational Site 14348 | Portland | Oregon | 97239 | — |
| Teva Investigational Site 14299 | Charleston | South Carolina | 29414 | — |
| Teva Investigational Site 14129 | Nashville | Tennessee | 37232 | — |
| Teva Investigational Site 14228 | Houston | Texas | 77030 | — |
| Teva Investigational Site 14223 | Richmond | Virginia | 23298 | — |
| Teva Investigational Site 14135 | Everett | Washington | 98201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03813238, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 7, 2023 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03813238 live on ClinicalTrials.gov.